Remove 2012 Remove FDA Remove Public Health
article thumbnail

Monthly Round-Up of What to Read on Pharma Law and Policy

Bill of Health

FDA lawsuit and its potential implications for pharmaceutical regulation, and an estimate of U.S. public investment in the development of mRNA COVID-19 vaccines. Eroding Judicial Deference to the FDA – Consequences for Public Health. JAMA Health Forum. J Health Polit Policy Law. N Engl J Med.

article thumbnail

Unlocking the mRNA Platform Technology: Walking the Talk with Investment Protection

Bill of Health

Together, these articles underscore the injustice of the present moment and emphasize the need to reform intellectual property protections for government-funded inventions of public health significance. Recent Research on Public Funding of mRNA Technology The first of the two new articles is an in-depth empirical study of U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

SQA Regulatory Surveillance Summary for March and April 2024

SQA

These variations are required to be assessed by the authorities based on their impact on public health and the medicine’s characteristics. In addition, the ISPE Guide outlines the authority of State Boards of Pharmacy and their coordination of oversight with the FDA. Science and safety are at our core.

FDA 40
article thumbnail

Free Speech versus Public Health: The Role of Social Media (Part Two)

Bill of Health

Haupt In addition to the conflict between free speech and public health in connection with social media , the role of social media as a public health hazard in itself has gained attention. He based this proposal on a range of alleged public health harms caused by social media, especially among young users.

article thumbnail

SQA Regulatory Surveillance Summary 5 | Monthly Update 2021

SQA

Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) and the United States Food and Drug Administration (FDA) released a series of policy recommendations to address the vulnerabilities in United States pharmaceutical supply chains. b) and 320.31(d)(3)).

FDA 83
article thumbnail

Lift the Blood Ban, But Don’t Penalize PrEP Users 

Bill of Health

Food and Drug Administration (FDA) announced that it is lifting its highly contested blood deferral policy for men who have sex with men (MSM, i.e., gay and bisexual men), colloquially known as the blood ban. This fits a paradigm I describe in recent work , the demedicalization of preventive health care.

FDA 228
article thumbnail

Top 10 Healthcare IT News stories of 2022

Healthcare It News

One example is partnering with Healthy Together, which uses the agency's API to provide veterans with secure mobile access to their health records. FDA authorizes at-home COVID-19 tests from Amazon, Roche, Siemens. And it will help public health officials improve public health policy and lower overall costs.

Nurses 355